Persistent T Cell Immunity Following Nipah Virus Infection: Evidence From Malaysian Survivors
Open Access
- 8 January 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (5) , e1261-e1266
Abstract
Nipah virus (NiV) induces strong humoral immunity, but the durability of NiV-specific memory T-cell responses remains unclear. We characterized cellular immunity approximately 25 years after infection in 4 survivors of the 1998 Malaysian outbreak. PBMCs were stimulated with overlapping peptide mini-pools spanning the NiV fusion (NiV-F) and attachment (NiV-G) glycoproteins, and responses were assessed using enzyme-linked immune absorbent spot and intracellular cytokine staining. Durable cytokine-producing T-cell responses were detected, with immunodominant epitopes in the NiV-G ectodomain. Survivors with neurological sequelae exhibited stronger T-cell responses and cognitive impairment, highlighting persistent cellular immunity decades after infection with implications for vaccine development.Keywords
Funding Information
- Coalition for Epidemic Preparedness Innovations (grant number IF037-2021)
- National University of Singapore
- CA.R.E. Fund
This publication has 13 references indexed in Scilit:
- Malaysia outbreak survivors retain detectable Nipah antibodies and memory B cells after 25 yearsJournal of Infection, 2025
- Comparative immune profiling in survivors of the 2023 Nipah outbreak in Kerala state, IndiaJournal of Medical Virology, 2024
- Twenty-five years of Nipah outbreaks in Southeast Asia: A persistent threat to global healthIJID Regions, 2024
- Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trialsTropical Medicine & International Health, 2024
- Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionThe Journal of Infectious Diseases, 2021
- Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of InfectionClinical Infectious Diseases, 2019
- Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infectionVaccine, 2016
- Human Ebola virus infection results in substantial immune activationProceedings of the National Academy of Sciences, 2015
- Nipah Virus-associated Encephalitis Outbreak, Siliguri, IndiaEmerging Infectious Diseases, 2006
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999